Douglas Kerr, Chief Medical Officer: Dyne Therapeutics DYN Sell · Filed 06/17

Trade details

Type: Insider sale
Amount: $16,258.71
Shares · price: 887 sh · $18.33 a share
Held after: 169,155 sh
Stock: Dyne Therapeutics DYN
Person: Douglas KerrChief Medical Officer
Trade date: 26/06/16
Filed: 26/06/17
Days to filing: 1 days

Sold 0.5% of holdings

Share of holding sold: 0.5%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 05/17~07/16

Douglas Kerr's recent trades

Douglas KerrChief Medical Officer
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$661
35 sh
$661
Filed 09/08
Traded 09/08
Douglas KerrChief Medical Officer
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$121.7K
5,000 sh
$121.7K
Filed 09/04
Traded 09/04
Douglas KerrChief Medical Officer
Planned saleDyne Therapeutics
Planned sale
Dyne Therapeutics
DYN
$64.2K
2,443 sh
$64.2K
Filed 08/13
Traded 08/13
Douglas KerrChief Medical Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$28.7K
1,564 sh
$28.7K
Filed 05/14
Traded 05/13
Douglas KerrChief Medical Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$13.5K
904 sh
$13.5K
Filed 03/06
Traded 03/05